why choose us

First received: March 01, 2024

Clinical Trial: A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Venous Thromboembolism

Study Type: INTERVENTIONAL


Official Title: A Master Protocol for a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of REGN9933 and REGN7508, Monoclonal Antibodies Against Factor XI for Prevention of Venous Thromboembolism in Patient

Brief Summary: This study is researching 2 different experimental drugs called REGN9933 and REGN7508 (called "study drugs").The study is focused on adults undergoing a placement of a catheter in the vein, also called a 'PICC line'.The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related disease after catheter placement.The study is looking at several other research questions, including:What side effects may happen from taking the study drugHow…

Read more